As of 2024-12-12, the Relative Valuation of Solid Biosciences Inc (SLDB) is (28.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.01 USD, the upside of Solid Biosciences Inc based on Relative Valuation is -664.9%.
The range of the Relative Valuation is (12.26) - (43.98) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 18.3x | 11.6x |
| Forward P/E multiples | 5.1x - 18.7x | 11.9x |
| Fair Price | (12.26) - (43.98) | (28.30) |
| Upside | -344.7% - -977.9% | -664.9% |
| Date | P/E |
| 2024-11-29 | -2.37 |
| 2024-11-27 | -2.37 |
| 2024-11-26 | -2.40 |
| 2024-11-25 | -2.44 |
| 2024-11-22 | -2.25 |
| 2024-11-21 | -2.18 |
| 2024-11-20 | -2.06 |
| 2024-11-19 | -2.13 |
| 2024-11-18 | -2.08 |
| 2024-11-15 | -2.02 |
| 2024-11-14 | -2.21 |
| 2024-11-13 | -2.31 |
| 2024-11-12 | -2.29 |
| 2024-11-11 | -2.49 |
| 2024-11-08 | -2.44 |
| 2024-11-07 | -2.40 |
| 2024-11-06 | -2.55 |
| 2024-11-05 | -2.47 |
| 2024-11-04 | -2.35 |
| 2024-11-01 | -2.39 |
| 2024-10-31 | -2.30 |
| 2024-10-30 | -2.38 |
| 2024-10-29 | -2.37 |
| 2024-10-28 | -2.43 |
| 2024-10-25 | -2.38 |
| 2024-10-24 | -2.33 |
| 2024-10-23 | -2.34 |
| 2024-10-22 | -2.37 |
| 2024-10-21 | -2.42 |
| 2024-10-18 | -2.75 |
| 2024-10-17 | -2.63 |
| 2024-10-16 | -2.92 |
| 2024-10-15 | -2.76 |
| 2024-10-14 | -2.54 |
| 2024-10-11 | -2.52 |
| 2024-10-10 | -2.52 |
| 2024-10-09 | -2.88 |
| 2024-10-08 | -2.95 |
| 2024-10-07 | -2.74 |
| 2024-10-04 | -2.74 |
| 2024-10-03 | -2.79 |
| 2024-10-02 | -2.75 |
| 2024-10-01 | -2.82 |
| 2024-09-30 | -2.90 |
| 2024-09-27 | -2.94 |
| 2024-09-26 | -3.02 |
| 2024-09-25 | -3.14 |
| 2024-09-24 | -3.20 |
| 2024-09-23 | -3.17 |
| 2024-09-20 | -3.27 |